BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26104998)

  • 1. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.
    Aukema SM; Theil L; Rohde M; Bauer B; Bradtke J; Burkhardt B; Bonn BR; Claviez A; Gattenlöhner S; Makarova O; Nagel I; Oschlies I; Pott C; Szczepanowski M; Traulsen A; Kluin PM; Klapper W; Siebert R; Murga Penas EM
    Br J Haematol; 2015 Sep; 170(6):814-25. PubMed ID: 26104998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.
    Havelange V; Ameye G; Théate I; Callet-Bauchu E; Mugneret F; Michaux L; Dastugue N; Penther D; Barin C; Collonge-Rame MA; Baranger L; Terré C; Nadal N; Lippert E; Laï JL; Cabrol C; Tigaud I; Herens C; Hagemeijer A; Raphael M; Libouton JM; Poirel HA;
    Genes Chromosomes Cancer; 2013 Jan; 52(1):81-92. PubMed ID: 23012230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.
    Maria Murga Penas E; Schilling G; Behrmann P; Klokow M; Vettorazzi E; Bokemeyer C; Dierlamm J
    Genes Chromosomes Cancer; 2014 Jun; 53(6):497-515. PubMed ID: 24590883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fish evaluation of additional cytogenetic aberrations and hyperdiploidy in childhood Burkitt lymphoma.
    Avgerinou G; Stefanaki K; Liapis K; Kostopoulos IV; Kossiva L; Tzoumaka-Bakoula C; Pavlidis D; Filippidou M; Katsibardi K; Ampatzidou M; Kattamis A; Polychronopoulou S; Mantzourani M; Papadhimitriou SI
    Leuk Lymphoma; 2022 Mar; 63(3):551-561. PubMed ID: 34727830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge.
    Boerma EG; Siebert R; Kluin PM; Baudis M
    Leukemia; 2009 Feb; 23(2):225-34. PubMed ID: 18923440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases.
    Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY
    Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Hodgkin's lymphomas with Burkitt-like cells are associated with c-Myc amplification and poor prognosis.
    Mossafa H; Damotte D; Jenabian A; Delarue R; Vincenneau A; Amouroux I; Jeandel R; Khoury E; Martelli JM; Samson T; Tapia S; Flandrin G; Troussard X
    Leuk Lymphoma; 2006 Sep; 47(9):1885-93. PubMed ID: 17065002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
    Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
    Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines.
    Karpova MB; Schoumans J; Blennow E; Ernberg I; Henter JI; Smirnov AF; Nordenskjöld M; Fadeel B
    Int J Oncol; 2006 Mar; 28(3):605-17. PubMed ID: 16465364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J
    Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel three-break rearrangement and cryptic translocations leading to colocalization of MYC and IGH signals in B-cell acute lymphoblastic leukemia.
    Tchinda J; Volpert S; Berdel WE; Büchner T; Horst J
    Cancer Genet Cytogenet; 2006 Mar; 165(2):180-4. PubMed ID: 16527615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia.
    Sandlund JT; Kastan MB; Kennedy W; Behm F; Entrekin E; Pui CH; Kalwinsky DT; Raimondi SC
    Cancer Genet Cytogenet; 2006 Jul; 168(1):69-72. PubMed ID: 16772123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
    Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
    J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isochromosome 1q in childhood Burkitt lymphoma: the first reported case in Korea.
    Rim JH; Kim HS; Shin S; Park SJ; Choi JR
    Ann Lab Med; 2015 Nov; 35(6):663-5. PubMed ID: 26354361
    [No Abstract]   [Full Text] [Related]  

  • 16. Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.
    De Souza MT; Hassan R; Liehr T; Marques-Salles TJ; Boulhosa AM; Abdelhay E; Ribeiro RC; Silva ML
    Pediatr Blood Cancer; 2014 Aug; 61(8):1422-6. PubMed ID: 24668946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08.
    Lones MA; Sanger WG; Le Beau MM; Heerema NA; Sposto R; Perkins SL; Buckley J; Kadin ME; Kjeldsberg CR; Meadows A; Siegel S; Finlay J; Bergeron S; Cairo MS;
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):169-78. PubMed ID: 15125609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study.
    García JL; Hernandez JM; Gutiérrez NC; Flores T; González D; Calasanz MJ; Martínez-Climent JA; Piris MA; Lopéz-Capitán C; González MB; Odero MD; San Miguel JF
    Leukemia; 2003 Oct; 17(10):2016-24. PubMed ID: 14513052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial cytogenetic alterations resulting in transformation of a low-grade follicular lymphoma to Burkitt lymphoma.
    Li L; Gupta S; Bashir T; Koduru PR; Brody J; Allen SL
    Cancer Genet Cytogenet; 2006 Oct; 170(2):140-6. PubMed ID: 17011985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.
    Burmeister T; Schwartz S; Horst HA; Rieder H; Gökbuget N; Hoelzer D; Thiel E
    Leukemia; 2005 Aug; 19(8):1391-8. PubMed ID: 15973450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.